json
{
“subject”: “Ribociclib API (UBX11) – GMP Supply & DMF/CEP Support for Abdi İbrahim”,
“content”: “
I understand that Abdi İbrahim is actively advancing its oncology pipeline and preparing for future generic entry opportunities. With the global market for Ribociclib expected to expand significantly ahead of the 2029 patent expiry, we believe an early supply partnership would provide Abdi İbrahim with a strategic advantage in securing regulatory-ready, commercially viable API for this high-value CDK4/6 inhibitor.
Our company, Unibest Industrial Co., Ltd., supplies Ribociclib API (UBX11) under strict GMP compliance, with full support for DMF/CEP/ASMF registration filings. Our production process is designed to meet stringent nitrosamine control requirements, ensuring compliance with global regulatory expectations including EMA and FDA standards. As a stable manufacturer, we can offer consistent commercial-scale supply to support your development needs from early-stage projects through to full commercialization.
With China-based cost advantages, flexible production capacities, and a professional trade team experienced in managing international API registrations, we are well positioned to serve as a reliable long-term supply partner for your portfolio. We would welcome the opportunity to discuss your specific requirements and explore a customized supply arrangement.
Would a brief call this week or next be convenient to assess potential synergies and next steps? In the meantime, samples and detailed technical documentation are available upon request.
For more product information, please visit: Chemical Compositions
For biological ingredients, please visit: Biological Ingredients
”
}